Cardiogen Research Guide

Full name: Cardiogen (Ala-Glu-Asp-Arg Cardiac Bioregulator)

A short synthetic peptide bioregulator from the Khavinson family targeted at cardiac (myocardial) tissue. It is used in the bioregulator community to support heart muscle function and cardiovascular resilience in short repeated courses.

How Cardiogen Works

As a signal peptide (Ala-Glu-Asp-Arg), it is proposed to regulate gene expression in myocardial tissue, supporting cardiomyocyte function, myocardial protein synthesis, and normal cardiac tissue maintenance.

Dosing Protocol

• Typical dose: ~1-2 capsules/day or short injectable courses
• Frequency: Once daily
• Duration: 10-30 day courses
• Route: Oral capsule or subcutaneous

Reported Benefits

• Cardiac/myocardial tissue support
• Cardiovascular resilience (proposed)
• Myocardial protein synthesis support
• Short course-based protocol

Potential Side Effects

• Limited Western clinical data
• Injection site reactions (injectable)
• Unknown long-term effects

Research Citations

1. Cardiac peptide bioregulators (2016) - Reported to support myocardial tissue function and protein synthesis in regional research studies.

Related Cardiovascular Compounds

• Nattokinase - Full Profile
• Serrapeptase - Full Profile
• CoQ10 - Full Profile
• Omega-3 (EPA/DHA) - Full Profile
• Bergamot Extract - Full Profile
• Telmisartan - Full Profile

View full Cardiogen profile with 3D molecule viewer →